Worldwide Assessment of Linezolid's Clinical Safety and Tolerability: Comparator-Controlled Phase III Studies

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial Agents and Chemotherapy 2003-06, Vol.47 (6), p.1824-1831
Hauptverfasser:	Rubinstein, Ethan, Isturiz, Raul, Standiford, Harold C, Smith, Leon G, Oliphant, Thomas H, Cammarata, Sue, Hafkin, Barry, Le, Vu, Remington, Jack
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetamides Acetamides - adverse effects Acetamides - therapeutic use Adolescent Adult Aged Anti-Infective Agents Anti-Infective Agents - adverse effects Anti-Infective Agents - therapeutic use Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Clinical Therapeutics Clinical Trials, Phase III as Topic Community-Acquired Infections - drug therapy Cross Infection - drug therapy Drug Interactions Female Gram-Positive Bacterial Infections Gram-Positive Bacterial Infections - drug therapy Humans Linezolid Male Medical sciences Middle Aged Multicenter Studies as Topic Oxazolidinones Oxazolidinones - adverse effects Oxazolidinones - therapeutic use Pharmacology. Drug treatments Protein Synthesis Inhibitors Protein Synthesis Inhibitors - adverse effects Protein Synthesis Inhibitors - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!